Earnings Feed
Start Free
Inhibrx, Inc.·4

Mar 22, 4:54 PM ET

Deck Kelly 4

4 · Inhibrx, Inc. · Filed Mar 22, 2024

Insider Transaction Report

Form 4
Period: 2024-03-20
Inhibrx, Inc.INBX
Deck Kelly
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-03-21$35.09/sh−3,113$109,230→ 18,130 total
    Exercise: $10.52Exp: 2028-11-26→ Common Stock (3,113 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-03-22$35.00/sh−110$3,850→ 18,020 total
    Exercise: $10.52Exp: 2028-11-26→ Common Stock (110 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-03-20$35.02/sh−16,777$587,552→ 21,243 total
    Exercise: $10.52Exp: 2028-11-26→ Common Stock (16,777 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on November 26, 2019, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.

Documents

1 file
  • 4
    wk-form4_1711140855.xmlPrimary

    FORM 4